The Max Foundation to Launch Treatment Access for Advanced Breast Cancer in Nine Countries Across Africa, Latin America, and South Asia in Q3 2023. Learn more
The Max Foundation 
The Malaysian Society of Hematology’s annual meeting, held earlier this year, took on special significance as it was the first face-to-face conference since the start of the COVID-19 pandemic. Chairperson,...
The Max Foundation 
Today is a difficult day, the anniversary of the day we lost Max to leukemia in 1991. The pain and feeling of emptiness remain with me, as real and tangible...
The Max Foundation 
After weeks of anxious anticipation, February 10, 2023, was a day of incredible joy for us as the first shipment of medication successfully arrived in our partner hospital in Laos...
The Max Foundation 
The Max Foundation to launch its Max Access Solutions program for patients with HR+/HER2- advanced breast cancer in collaboration with leading oncologists in low- and middle-income countries (LMICs) and the...
SEATTLE, Washington – May 17, 2023 – The Max Foundation (Max), a global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and supportive services to patients worldwide,...
Availability of Novartis Scemblix® (asciminib) starting in 2023 helps ensure people living with later lines of CML in low-income countries have access to the latest innovation SEATTLE – Dec. 12,...
Sign up to hear about our latest stories, news, and upcoming events.